HHS 2020 Benefit Limits and UpdatesThe Department of Health and Human Services (HHS) has released final regulations with the benefit and payment parameters for plan years beginning on or after January 1, 2020, along with a few other insurance market and Exchange-related final regulations. Although largely aimed at insurers and state regulators, the regulations include provisions of interest to employers and their advisors. Here are two key highlights.
A. Annual Cost-Sharing Limits. HHS has increased the maximum annual limitation on cost-sharing for 2020 to $8,150 for self-only coverage and $16,300 for other than self-only coverage (up from $7,900 and $15,800 for 2019).
HHS finalized a proposed change to the way it calculates this adjustment that takes into account increases in individual health insurance premiums, acknowledging that the change will result in higher cost-sharing limits. The final limits for 2020 are less than the proposed limits because data inputs used in the formula were updated after publication of the proposed regulations. This formula also affects adjustments to employer shared responsibility penalties under Code § 4980H.
B. Generic Drugs.Health plans are not required to count drug manufacturer coupons toward the annual limit on cost-sharing when a medically appropriate generic equivalent is available.
There were additional updates about the Exchange & SHOP Enrollment and the so-called “Silver Loading” – a state-level practice that allows insurers to increase premiums on silver-level Exchange plans to compensate for reduced federal reimbursements. Those details can be found in the Fact Sheet linked below.
Links:
We’ve all heard the phrase “doctor’s orders,” from a family member or friend reminding us to eat healthy or take our medicine. But it’s not a catchphrase. The advice a doctor provides is a real plan...
As healthcare systems grow more complex, as does the complexity for consumers trying to manage and understand their benefits. Yet many of the systems designed to support them often lack clarity and...
On June 30, 2025, the U.S. Supreme Court announced its decline to review decision in Pharmaceutical Care Management Association (PCMA) v. Mulready, a ruling by the U.S. Court of Appeals for the 10th...